Abciximab-associated pseudothrombocytopenia.
Wool
Ronald L
RL
Coleman
Teresa A
TA
Hamill
Randy L
RL
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D010976:Platelet Count; D018570:Risk Assessment; D015607:Stents; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab